Bill > S61

Introduced Session

A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada. This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

AI Summary

Committee Categories

Chuck Grassley (R)*,  Tammy Baldwin (D),  Sherrod Brown (D),  Susan Collins (R),  Maggie Hassan (D),  Angus King (I),  Amy Klobuchar (D),  Patrick Leahy (D),  Jeff Merkley (D),  Gary Peters (D),  Jeanne Shaheen (D),  Sheldon Whitehouse (D),  Ron Wyden (D), 

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 01/09/2019)

Official Document